Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio by Jing Liu, Hongye Peng, Che Wang, Yutong Wang, Rongrui Wang, Jixiang Liu, Tianhui Zhou, Shukun Yao

“…As one of the most common chronic liver diseases, metabolic dysfunction-associated fatty liver disease (MAFLD) had different prognoses between mild and moderate-severe levels. …”
Get full text

Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population by Guangya Chen, Yi Lv, Wei Ni, Qingxin Shi, Xingliang Xiang, Sen Li, Chengwu Song, Mingzhong Xiao, Shuna Jin

“…There is a limited diagnosis of nonalcoholic fatty liver disease (NAFLD). Thus, the noninvasive assessments are worth exploring. …”
Get full text

Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis by George Koulaouzidis, Dafni Charisopoulou, Michał Kukla, Wojciech Marlicz, Grażyna Rydzewska, Anastasios Koulaouzidis, Karolina Skonieczna-Żydecka

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study by Irena Ciećko-Michalska, Małgorzata Szczepanek, Beata Tobiasz-Adamczyk, Tomasz Mach

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China by M. Ch. Semenistaya, Fan Jian-Gao, O. B. Velichenko, Ye. A. Kuznetsova, Ch. S. Pavlov

“…To present comparative assessment of diagnostic and treatment approaches at non-alcoholic fatty liver disease (NAFLD) in the Russian Federation and People’s Republic of China. …”
Get full text

A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice by Peng Ma, Rongrong Huang, Yu Ou

Subjects: Get full text

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway by Peng Yu, Xi Xu, Jing Zhang, Xuan Xia, Fen Xu, Jianping Weng, Xiaoyang Lai, Yunfeng Shen

“…A glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (LR) had been experimentally and clinically shown to ameliorate nonalcoholic fatty liver disease (NAFLD). This study aimed to investigate the beneficial effect of LR on NAFLD in vivo and in vitro and its underlying molecular mechanism. …”
Get full text

Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus by Xiaoyi Qian, Wenwen Wu, Boyang Chen, Simin Zhang, Chunmei Xiao, Long Chen, Jun Chen, Jun Chen, Lingli Ke, Meian He, Xiulou Li, Xiulou Li, Xiulou Li

Subjects: Get full text

Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999–2002 by Janet M. Wojcicki, David Rehkopf, Elissa Epel, Philip Rosenthal

Get full text

The association between the dietary index for gut microbiota and metabolic dysfunction-associated fatty liver disease: a cross-sectional study by Yangyang Zheng, Jinhui Hou, Shiqi Guo, Jinghai Song

Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text

The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014 by Ruli Wang, Ningxi Wu, Huan Qu, Xiaowei Zheng, Haoyang Zhang, Lihong Zhu, Xiaolei Wang, Xiaodie Yao, Le Zhang

“…BackgroundPrevious research has indicated that long working hours are connected to a variety of health conditions, including nonalcoholic fatty liver disease (NAFLD). However, this association which has been observed in more population is limited. …”
Get full text

Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review by Hongcai Li, Jingjing Liang, Mengzhen Han, Zhenpeng Gao

Subjects: “…Non-alcoholic fatty liver disease…”
Get full text

The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity by Ying Wang, Shuyi Yang, Suming Zhang, Suming Zhang, Ye Yang, Siqing Li, Siqing Li, Meiyu Zhang, Meiyu Zhang, Xiaona Li, Hua Bai, Peiliang Luo, Yingdi Yuan, Yingdi Yuan

Subjects: “…metabolic dysfunction-associated fatty liver disease (MAFLD)…”
Get full text

Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by Yuan-Yuan Xu, Xu Wang, Yu-Qing She, Jie Liu, Qing Zhang

“…This study aimed to systematically evaluate the efficacy of liraglutide in treating type 2 diabetes mellitus (T2DM) complicated with non-alcoholic fatty liver disease (NAFLD) by comparing liraglutide with placebo or other drugs (mainly insulin). …”
Get full text

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease by Yu-Ming Cheng, Tsung-Han Hsieh, Shan-Wen Wang, Chia-Chi Wang, Jia-Horng Kao

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

The effects of kefir drink on liver aminotransferases and metabolic indicators in patients with nonalcoholic fatty liver disease: a randomized controlled trial by Farzaneh Mohammadi, Nadia Razmjooei, Mohammad Ali Mohsenpour, Mohammad Ali Nejati, Mohammad Hassan Eftekhari, Najmeh Hejazi

Subjects: “…Non-alcoholic fatty liver disease (NAFLD)…”
Get full text

Plasma Adiponectin and Its Correlation with Carotid Intima-Media Thickness in Obesity and in Type 2 Diabetes and Nonalcoholic Fatty Liver Disease by Maha Hussein, Aasem Saif, Mona Amin, Osama Khalafallah, Ahmed Hussien, Samar Aboulsoud, Shrook Mousa

“…Also, it was reported in patients with nonalcoholic fatty liver disease (NAFLD). We assessed plasma adiponectin and its correlation with carotid intima-media thickness (CIMT), as a marker of atherosclerosis, in Egyptian patients with NAFLD. …”
Get full text

The Impact of Sira Vedha (Phlebotomy) at the Right Elbow Joint in the Treatment of Non-Alcoholic Fatty Liver Disease - A Research Report by Gaurav Sawarkar, Punam Sawarkar

“…Non-alcoholic fatty liver disease (NAFLD) affects 9%–53% of the Indian population. …”
Get full text

Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis by Bei Li, Chuan Zhang, Yu-Tao Zhan

“…With the growing epidemic of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide and will become one of the leading causes of cirrhosis. …”
Get full text

Identification of biomarkers for the diagnosis of type 2 diabetes mellitus with metabolic associated fatty liver disease by bioinformatics analysis and experimental validation by Guiling Wu, Guiling Wu, Sihui Wu, Sihui Wu, Tian Xiong, Tian Xiong, Tian Xiong, You Yao, You Yao, Yu Qiu, Yu Qiu, Yu Qiu, Liheng Meng, Cuihong Chen, Xi Yang, Xi Yang, Xi Yang, Xinghuan Liang, Yingfen Qin

Subjects: “…metabolic associated fatty liver disease…”
Get full text